Schumer Wants To Up Pharma Reform Ante To $106 Bil. Via Medicare Rebates
Sen. Chuck Schumer is looking to revive the idea of getting more savings from the pharmaceutical industry than the $80 billion already pledged toward health reform and is eyeing Senate floor debate as the venue
You may also be interested in...
Democratic Sen. Bill Nelson of Florida may have made a tactical error in bringing up an amendment to mandate drug rebates under Medicare Part D during the Senate Finance Committee's markup of health reform legislation
The introduction of the Senate Finance Committee's health care proposal turns the focus from what the pharmaceutical industry will contribute to reform efforts toward what manufacturers stand to gain
The Pharmaceutical Research and Manufacturers of America is expecting to make good on its pledge to contribute $80 billion to health care reform through a combination of drug rebates and fees, in addition to savings from follow-on biologics and the previously announced 50 percent discount on drugs used in the Medicare Part D donut hole